Drug Abuse Aspects of Hiv/Aids and Other Infections

The summary for the Drug Abuse Aspects of Hiv/Aids and Other Infections grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Drug Abuse Aspects of Hiv/Aids and Other Infections: The National Institute on Drug Abuse (NIDA) supports research on the natural history, epidemiology, etiology, virology and pathogenesis, prevention, and treatment of drug abuse and drug abuse aspects of HIV/AIDS and other infectious agents [e.g., hepatitis B virus (HBV), hepatitis C virus (HCV), other sexually transmitted infections (STIs), and tuberculosis (TB)]. AIDS was first recognized as a growing epidemic among men who have sex with men (MSM) and injection drug users (IDUs) and their sexual partners in the early 1980s. While considerable scientific progress has been made since then in understanding, preventing, and treating the intertwined epidemics of drug abuse and HIV/AIDS, much remains unknown or poorly understood today. Emerging drugs of abuse, such as the club drugs ecstasy (MDMA), GHB, ketamine, and methamphetamine, as well as more potent supplies of heroin, cocaine, and marijuana, are continually changing the profiles of populations at risk. Moreover, these drugs often contain adulterants, and are used in risky social contexts in combination with alcohol and other drugs, including Viagra, poppers, and tobacco. In the United States today, over 77,000 women have been diagnosed with AIDS attributed to injection drug use or sex with an IDU, and nearly a third of AIDS cases in adult/adolescent women diagnosed in 2001 reported injection drug use or sex with an IDU as their primary risks. Racial and ethnic minority populations of both genders have been deeply affected by drug abuse, HIV/AIDS, and other infectious diseases in recent years, with new HIV infections continuing at an alarming rate in the U.S. and in other nations. There are an estimated 800,000 to 900,000 people living with HIV in the U.S., with approximately 40,000 new HIV infections occurring every year. By race, more than half of new HIV infections in 2001 and deaths attributable to AIDS in 2000 occurred among African Americans, although they represent only 13% of the U.S. population. This PA seeks to stimulate a range of investigator-initiated studies to advance the scientific knowledge base on drug abuse aspects of HIV/AIDS and other serious infections. Researchers are invited to address diverse and cross-cutting issues in multiple disciplines, including, among others: virology, bacteriology, molecular epidemiology, etiology, therapeutics and vaccines, ethnography and behavioral epidemiology, mathematical modeling and simulations, and the behavioral and social sciences.
Federal Grant Title: Drug Abuse Aspects of Hiv/Aids and Other Infections
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-04-007
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announcement for details.
Posted Date: Oct 22, 2003
Creation Date: Oct 22, 2003
Archive Date: Nov 09, 2006
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-04-007.html http://grants.nih.gov/grants/guide/pa-files/PA-04-007.html
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School...
Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21)
Extracellular Vesicles in HIV/AIDS and Substance Abuse (R01)
The National Drug Abuse Treatment Clinical Trials Network (UG1)
Long-Term Outcomes of Bariatric Surgery Using Large Datasets (R01)
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Epidemiology of Drug Abuse
Prescription Drug Abuse
More Grants from the National Institutes of Health
Analyses of Datasets on Older Populations with High Prevalence of Mobility Disability to D...
Consortium on Biomarker and Outcome Measures of Social Impairment for Use in Clinical Tria...
Clinical and Translational Science Award (U54)
NIAID Career Transition Award (K22)
Epigenetic Analyses of Aging as a Risk Factor for Multiple Chronic Conditions (U34)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2014 FederalGrants.com